Background. Although cardiopulmonary bypass is associated with systemic complement activation and neutrophil sequestration, it is unclear whether bypass-induced vascular injury is localized and dependent on organ ischemia. We hypothesized that other factors perhaps related to placement of a bypass circuit or to blood perfusion of a pump-oxygenator system may produce vascular injury caused by systemically circulating mediators. In dogs, we determined whether application of a systemic venoarterial bypass circuit with pump-oxygenator perfusion but without pulmonary or cardiac flow diversion (peripheral bypass) leads to vascular injury. Since several features of the postperfusion syndrome after bypass resemble sequelae of endotoxin exposure, we also measured circulating endotoxin and tumor necrosis factor levels.
Complement activation that occurs with bypass could mediate bypass-induced organ dysfunction and vascular injury.2,3'7'8 However, several recent studies suggest that complement activation alone is not sufficient to cause vascular injury and that other factors, including local ischemia and neutrophil priming by other mediators, are necessary.18-20 A role for endotoxin in bypassinduced vascular injury seems possible, because several features of the "postperfusion" syndrome, including multiorgan dysfunction, circulating neutropenia with tissue neutrophil sequestration, eicosanoid production, lipid peroxidation, and complement activation, have been observed in sepsis or after the administration of endotoxin. 21, 22 In addition, Rocke et a123 and Kharazmi and coworkers24 reported increases in circulating endotoxin levels in patients undergoing bypass. Thus, endotoxin and, therefore, tumor necrosis factor (TNF), [25] [26] [27] an important mediator of endotoxin-induced vascular injury, could play roles in bypass-induced vascular injury.
We performed studies in dogs to determine whether peripheral placement of a pump-oxygenator in a systemic venoarterial circuit (peripheral bypass) causes pulmonary and coronary vascular injury independent of blood flow diversion and whether this is associated with increases in circulating endotoxin and/or TNF. As indexes of vascular injury, pulmonary and coronary vascular protein permeability were measured with a previously described double indicator radioisotope protein leak index (PLI). [28] [29] [30] [31] We found that peripheral bypass increased pulmonary and coronary vascular permeability with associated complement activation and increases in circulating endotoxin and TNF.
Methods
Mongrel dogs (n= 17; weight, 23.7±2.4 kg) were preanesthetized with thiamylal (100 mg/kg), intubated, ventilated, and anesthetized with 0.5% intravenous chloralose (100 mg/kg bolus plus 20 mg kg`1 mink infusion). Catheters were inserted into the pulmonary artery and aorta for pulmonary artery, pulmonary artery wedge (PAWP), and arterial pressure measurements, blood sampling, and drug administration. Respiratory rate and tidal volume were set to maintain physiological blood gases, and 2 cm of positive endexpiratory pressure was added. Temperature was monitored with an esophageal probe. Cardiac output and pulmonary blood flow were measured by the dye dilution method with indocyanine green dye using a Waters densitometer and an on-line computer.
To avoid the effects of cardiopulmonary blood flow diversion (and resultant cardiac and pulmonary ischemia), hypothermic cardioplegic arrest, and heparinprotamine interactions, a peripheral venoarterial bypass circuit was used. Cannulas for bypass were inserted into the femoral vein (22F) and artery (16F) and, when necessary for adequate pump flow, into the internal jugular vein as well. After insertion of the cannulas, heparin (100 U/kg) was administered and additional heparin given thereafter to maintain the activated clotting time at .400 seconds. After baseline measurements, femoral venoarterial bypass was begun by connecting the cannulas to a bypass pump-oxygenator circuit consisting of a large-diameter roller-head pump (Model 2000, Sarns, Inc), bubble oxygenator, and heat exchanger. The pump circuit was primed with warmed normal saline. Oxygen at 10 L/min was infused into the oxygenator. Pump flow was initiated at a flow rate of 100 mL-kg-1. min'. Additional saline was given as necessary to maintain a mean blood pressure >90 mm Hg. To minimize the likelihood that our procedures could introduce exogenous endotoxin, we used new, disposable equipment for the bypass circuit, including cannulas and gas exchangers for each experiment, and intravenous solutions were all commercial human-grade preparations.
The experimental protocol used is outlined in Fig 1 . Bypass was maintained for 2 hours. During this period, there was spontaneous cardiac activity, and the lungs were ventilated with room air. At the termination of bypass, residual blood in the extracorporeal circuit was returned to the animal and the cannulas were clamped and disconnected from the bypass circuit but left in place. No protamine was given. Gamma probes were then positioned over both lungs for the measurement of pulmonary vascular protein leak. Radiolabeled autologous protein and erythrocytes (RBCs) were injected into the femoral artery. External lung counts and blood samples were obtained during the next 60 minutes, after which the animals were killed with an overdose of pentobarbital. The lungs were clamped at the hila and excised, and the heart was also removed. The heart and lungs were cleaned of excess blood, and tissue samples were taken for protein and RBC counts, histology, and gravimetric water content measurements, as outlined below. Central venous blood specimens for cell counts (hematocrit, leukocytes, platelets), total protein, complement (CH50), endotoxin, and TNF were taken before bypass (baseline), during early (30 minutes) and late (90 minutes) bypass, and 60 minutes after bypass.
Assessment of Permeability
The assessment of pulmonary and coronary vascular protein permeability using the double radioisotope PLI method has been described in detail previously. [28] [29] [30] [31] Briefly, the rate of accumulation of extravascular radio- Central venous blood specimens were collected in endotoxin-free sterile tubes (Gibco), the samples were centrifuged (20 minutes at 2500 rpm), and the plasma was removed and frozen immediately at -70°C. The samples were thawed once for endotoxin and TNF assays and again for complement measurements. The investigator performing the assays was blinded as to experimental groups and in vivo results. The total protein content (,ug/mL) of each specimen was measured by the method of Bradford.32 Measured complement, endotoxin, and TNF levels were normalized for dilutional changes during bypass by use of the measured total protein content of each plasma sample according to the formula: normalized level=measured level/(measured sample protein content/baseline sample protein content). Samples from one control and one bypass animal were contaminated in storage and therefore were not assayed and are not included in the results.
TNF activity was measured using a modification33 of the cytotoxicity assay of Ruff and Gifford.34 Cultured L929 cells were seeded at a density of 5.5 x 105 cells/mL and incubated for 20 hours in Dulbecco's modified Eagle's medium (Whittaker Bioproducts, Inc, Walkerville, Md) supplemented with 10% heat-inactivated fetal calf serum, 0.29 mg/mL L-glutamine, 100 U/mL penicillin, and 100 ,ug/mL streptomycin. After incubation, the old medium was removed. Fresh medium, 100 ,uL of sample (or standard), and 100 ,uL of 1 L/min, bypass vs baseline) in contrast to nearly zero pulmonary blood flow in studies using total diversion of right heart venous return. As expected, circulating leukocyte and platelet counts decreased during bypass and remained lower at 1 hour after bypass, although the changes were less dramatic when normalized for hemodilution. Control animals exhibited a decrease in circulating neutrophils during the sham bypass period that returned to baseline by the end of the experimental protocol. Hematocrit (37.9±2.1% vs 27.4+3.6%; P<.05) and total plasma protein (52.2±2.1 vs 32.2±5.4 mg/mL; P<.05) decreased from baseline during bypass and remained low after bypass.
Protein Leak Index
Bypass caused a greater than threefold increase in the external probe-based pulmonary PLI and more than a twofold increase in the tissue-based coronary PLI compared with controls (Fig 2) . PLI data are summarized in vs sham bypass; P=NS). These changes in circulating levels were also evident using raw levels without normalization for dilutional changes. Peak endotoxin and minimum CH50 levels correlated poorly with postbypass pulmonary (Fig 5) and coronary protein leak (data not shown). In contrast, peak TNF levels during bypass correlated with pulmonary and with coronary protein leak (Fig 6) . The correlation was still evident using TNF levels that were not normalized for dilutional changes. TNF levels correlated poorly with endotoxin levels (data not shown).
Histology
Lung histology revealed an increased number of neutrophils in lung tissue of animals (n=3) after bypass compared with control (n=3) animals (0.2+0.2 vs 0.5+±0.8 cells per alveolar intercept per high-power field). There was evidence of tissue injury, and in some cases significant interstitial edema was present in dogs subjected to bypass that was not observed in controls.
Discussion
These studies show that peripheral bypass causes pulmonary and coronary vascular injury in the absence of cardiopulmonary flow diversion and in association with the appearance of circulating endotoxin and TNF. The changes were substantial: after bypass, pulmonary vascular protein leak increased nearly fourfold, and coronary vascular protein leak increased more than twofold. In addition, there was a threefold increase in the escape rate of radiolabeled protein from the intravascular compartment, suggesting a generalized increase in permeability. The increase in pulmonary protein leak was comparable to that observed in our previous studies of canine endotoxin lung injury.30 The (n=S) increase in coronary protein leak was comparable to those we have reported with myocardial ischemia-reperfusion injury.29 Lung, but not myocardial, water content was increased after bypass despite low hydrostatic pressures (PAWP), and lung water increased substantially after bypass with moderate left atrial pressure elevation, suggesting a physiologically significant increase in permeability. In previous studies from our laboratory, similar elevations of hydrostatic pressure did not increase lung water in animals with normal permeability.
Whether circulatory bypass with a pump-oxygenator causes vascular injury has been an unsettled question. Ratliff et a19 observed histological evidence of lung injury in dogs after bypass, as did Anyanwu et al14 in clinical studies, suggesting that pulmonary vascular injury occurred with bypass. However, Pitt and coworkers10 studied dogs undergoing 1, 2, or 3 hours of left heart bypass (with cardiopulmonary blood flow diversion) or right heart bypass (venovenous bypass without cardiopulmonary blood flow diversion) using transpulmonary metabolism of prostaglandin E1 as an index of vascular function. Evidence of pulmonary vascular injury developed only after prolonged (3-hour) left heart bypass, and even then, only mild injury was observed. Using a similar method (transpulmonary serotonin extraction) to assess pulmonary vascular function, Dargent et al"l and later Gillis et a135 also found no evidence of vascular injury in patients undergoing bypass. However, measurements of transpulmonary metabolism of vasoactive compounds can be affected by changes in perfused surface area, rate of blood flow, and metabolism kinetics that complicate their interpretation.'0 1135 In contrast to these findings, experimental studies by Demling and coworkers'3 and clinical studies by Byrick et a136 showed significant increases in lung water, which Since blood flow is diverted from the cardiopulmonary circulation during conventional cardiopulmonary bypass, the heart and potentially the lungs are ischemic. Thus, clinical and previous experimental studies have not distinguished between direct localized injury caused by near total diversion of blood flow and indirect injury possibly caused by circulating mediators. In our studies, pulmonary and coronary vascular permeability increased after peripheral use of a pumpoxygenator without cardiopulmonary flow diversion. In our experiments, however, pulmonary blood flow was substantially decreased but remained at 50% of control values and was thus much greater than is seen with conventional cardiopulmonary bypass; it was probably sufficient to maintain nutrient flow to the lungs and thus did not represent clear ischemia. Also, although the venoarterial circuit we used reduces systemic venous return and pulmonary arterial blood flow, it augments systemic arterial flow so that bronchial and coronary flows are likely to be preserved, and these beds are probably not ischemic. This suggests an indirect, possibly humoral mechanism of vascular injury. Clinical postbypass dysfunction of organs not evidently ischemic,1'2 such as brain,4 kidney,3 and gut,17 could reflect indirect vascular injury.
Complement activation has been suggested as an important potential mediator of bypass-induced vascular injury.2,67 As in previous clinical and experimental studies of full bypass with cardiopulmonary blood diversion,3'7'81013'15"6 we observed substantial complement activation, with decreased circulating leukocyte counts and histological evidence of pulmonary leukocyte sequestration. It is uncertain, however, whether complement activation alone is able to induce vascular injury. Henson and coworkers18 reported that complement activation failed to increase pulmonary vascular permeability in rabbits and suggested that complement activation alone, although necessary, was insufficient to cause vascular injury. Smedly et al19 found that in vitro stimulation of neutrophils with complement (C5a) or with formyl-methionyl-leucyl-phenylalanine caused little injury of cultured endothelial cells. However, both Henson and Smedly found that lipopolysaccharide (endotoxin) even in small amounts (1 to 10 ng/mL in vitro) greatly potentiated complement-mediated vascular injury. Bishop et al,20 studying pulmonary ischemia-reperfusion injury in rabbits, found that although systemic COMPLEMENT (CH50, U/mi) complement activation developed with even localized ischemia and reperfusion, vascular injury was not prevented by complement depletion. We found that vascular injury with peripheral bypass was associated with circulating endotoxin and TNF. Further, the severity of vascular injury was correlated with peak TNF levels but not with peak endotoxin or minimum complement (CH5O) levels. A potential role for endotoxin has also been suggested by reports of endotoxemia during bypass in patients.23 24 Also, several features of bypass postperfusion syndrome including multiorgan dysfunction, neutrophil sequestration, vascular injury, altered vasoreactivity, circulating eicosanoids, and tissue peroxidation resemble the sequelae of endotoxemia or sepsis. 21, 22, 26, 27, 30, 37 TNF is a potent polypeptide cytokine mediator of endotoxininduced vascular injury and neutrophil activation2526 capable of producing increased vascular permeability, neutrophil activation and adherence, organ leukocyte sequestration, neutrophil priming, and stimulation of endothelial interleukin-1 production, itself a cytotoxic cytokine.252637-39 The INF levels in our studies are comparable to levels that produce endothelial injury and neutrophil activation in vitro37-39 and to circulating levels present after endotoxin administration. 27 Several problems arise in the interpretation of our studies. Our indicators of vascular permeability, the PLIs, are ratios of transvascular protein extravasation to tissue blood content. The denominator acts to minimize the effect of changes in vascular exchange area on protein transfer.28 However, this introduces the possibility that observed increases in leak index might reflect decreases in blood content, perhaps resulting from vasoconstriction, rather than increased protein efflux. To address this issue, we have compared our corrected indexes with measures of raw protein efflux without the blood content correction and find that this measure increased by 8.5-fold with bypass, similar to changes in the corrected indexes, indicating that the change in leak index was a result of increased protein efflux. Our measure of generalized vascular leak, the labeled protein disappearance half-time, is based on protein content per gram of plasma and could have been influenced by fluid infusions with hemodilution. However, this effect would be reflected in the change in RBC halftime, which was reduced by only 6% with bypass compared with a 65% decrease in protein half-time (Table  3) . The difference in these decay curves suggests a significant effect on protein extravasation.
Finally, our finding of increased vascular leak in association with increased circulating levels of complement, endotoxin, and TNF does not indicate whether these agents mediate the observed changes in vascular permeability. Further studies using inhibitors or block- 
